Oosthoek, M., Vermunt, L., Wilde, A. d., Bongers, B., Antwi-Berko, D., Scheltens, P., . . . Teunissen, C. E. (2024). Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer’s disease: A systematic review. Alzheimer’s Research & Therapy, 16(1), 1-13. https://doi.org/10.1186/s13195-024-01456-1

Oosthoek, Marlies, Lisa Vermunt, Arno de Wilde, Bram Bongers, Daniel Antwi-Berko, Philip Scheltens, Pieter van Bokhoven, Everard G. B. Vijverberg, and Charlotte E. Teunissen. "Utilization of Fluid-based Biomarkers as Endpoints in Disease-modifying Clinical Trials for Alzheimer’s Disease: A Systematic Review." Alzheimer’s Research & Therapy 16, no. 1 (2024): 1-13. https://doi.org/10.1186/s13195-024-01456-1.

Oosthoek, Marlies, et al. "Utilization of Fluid-based Biomarkers as Endpoints in Disease-modifying Clinical Trials for Alzheimer’s Disease: A Systematic Review." Alzheimer’s Research & Therapy, vol. 16, no. 1, 2024, pp. 1-13, https://doi.org/10.1186/s13195-024-01456-1.